Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation

Published:2019-12 Issue:12 Volume:25 Page:2490-2500
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Pagliuca Simona,Bommier Côme^ORCID,Michonneau David,Meignin Veronique,Salmona Maud,Robin Marie,Prata Pedro Henrique,Xhaard Aliénor,de Fontbrune Flore Sicre,Feghoul Linda,Dhedin Nathalie,de Latour Régis Peffault,Caillat-Zucman Sophie^ORCID,Goff Jérôme Le^ORCID,Socié Gérard

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference51 articles.

1. Complications of allogeneic hematopoietic stem cell transplantation;Arnaout;Cancer Invest,2014

2. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective;Tomblyn;Biol Blood Marrow Transplant,2009

3. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines;Styczynski;Haematologica,2016

4. Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

5. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study;Curtis;Blood,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder;Experimental Hematology & Oncology;2024-08-19

3. Who is the patient at risk for EBV reactivation and disease: expert opinion focused on post-transplant lymphoproliferative disorders following hematopoietic stem cell transplantation;Expert Opinion on Biological Therapy;2023-03-28

4. Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017;Annals of Medicine;2022-02-23

5. Viral Cytotoxic T Lymphocytes (CTLs): From Bench to Bedside;Cancer Drug Discovery and Development;2022